Benefits of pamidronate in children with osteogenesis imperfecta: an open prospective study.
Joint Bone Spine. 2005 Jul
Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric
outcome.
J Bone Miner Res. 2005 July
Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral
gains but not short-term functional improvement.
J Bone Miner Res. 2005 Jun
Bone healing in children with osteogenesis imperfecta treated with bisphosphonates.
J Pediatr Orthop. 2005 May-Jun
A comparison of oral and intravenous bisphosphonate therapy for children with osteogenesis imperfecta.
J Pediatr Endocrinol Metab. 2005 Jan
The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with
osteogenesis imperfecta.
Turk J Pediatr. 2004 Oct-Dec
Pamidronate treatment of less severe forms of osteogenesis imperfecta in children.
J Pediatr Endocrinol Metab. 2004 Nov
Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
Bone. 2004 Nov
Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate.
Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta.
Bone. 2004 Jul
Intravenous pamidronate treatment in children with moderate to severe osteogenesis imperfecta: assessment
of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy.
Bone. 2004 Mar
Effectiveness of pretreatment in decreasing adverse events associated with pamidronate in children and adolescents.
Pharmacotherapy. 2004 Feb
Rapid Increase in Grip Force After Start of Pamidronate Therapy in Children and Adolescents With Severe
Osteogenesis Imperfecta
PEDIATRICS Vol. 111 No. 5 May 2003
Height and weight development during four years of therapy with cyclical intravenous pamidronate in children
and adolescents with osteogenesis imperfecta types I, III, and IV.
Pediatrics. 2003 May
Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous
pamidronate therapy.
J Bone Miner Res. 2003 Apr
Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism.
J Clin Endocrinol Metab. 2003 Mar
Improvement of bone in patients with osteogenesis imperfecta treated with pamidronate-lessons from biochemistry.
J Clin Endocrinol Metab. 2003 Mar
Intravenous bisphosphonate therapy in children with osteogenesis imperfecta.
Pediatrics. 2003 Mar
Modern approach to children with osteogenesis imperfecta.
J Pediatr Orthop B. 2003 Mar
Effect of cyclical intravenous pamidronate therapy in children with osteogenesis imperfecta. Open-label
study in seven patients
Joint Bone Spine. 2002 Oct
Osteogenesis imperfecta and intravenous pamidronate
Arch Dis Child. 2002
The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis
imperfecta.
J Clin Invest. 2002 Nov
Modeling the benefits of pamidronate in children with osteogenesis imperfecta.
J Clin Invest. 2002 Nov
Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta
Arch Dis Child. 2002 May
Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at
onset of treatment, predicted collagen mutation and treatment response.
J Pediatr Endocrinol Metab. 2002 Feb
Cyclic pamidronate infusion improves bone mineralisation and reduces fracture incidence in osteogenesis
imperfecta.
Eur J Pediatr. 2001 Nov
Efficacy of low dose schedule pamidronate infusion in children with osteogenesis imperfecta
J Pediatr Endocrinol Metab. 2001 May
Bisphosphonate therapy for severe osteogenesis imperfecta
J Pediatr Endocrinol Metab. 2000 Sep
Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age
J Clin Endocrinol Metab. 2000 May
Cyclic administration of pamidronate in children with severe osteogenesis imperfecta
N Engl J Med. 1998 Oct
Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta
Acta Paediatr. 1998 Jan-----(Sweden)
Intravenous pamidronate treatment in osteogenesis imperfecta.
J Pediatr. 1997 Oct---(Italy)
Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis.
Medicine (Baltimore). 1997 Jul---(The Netherlands)
Is APD a promising drug in the treatment of severe osteogenesis imperfecta?
J Pediatr Orthop. 1988 Jan-Feb----(Belgium)
